Factor V de Leiden (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Factor V de Leiden" in Galician language version.

refsWebsite

Global rank Galician rank

9nih.gov

4^th place

6^th place

5doi.org

2^nd place

7^th place

1msssi.gob.es

low place

2,805^th place

1web.archive.org

1^st place

1haematologica.org

low place

1archive.org

6^th place

8^th place

1pharmgkb.org

low place

1ahajournals.org

3,608^th place

2,169^th place

1genome.gov

9,308^th place

4,674^th place

ahajournals.org

circ.ahajournals.org

Factor V Leiden. Circulation. http://circ.ahajournals.org/content/107/15/e94

archive.org

De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis 24 (4): 367–79. PMID 9763354. doi:10.1055/s-2007-996025.

doi.org

dx.doi.org

Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA 277 (16): 1305–7. PMID 9109469. doi:10.1001/jama.277.16.1305.
Gregg JP, Yamane AJ, Grody WW (decembro de 1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". American Journal of Medical Genetics 73 (3): 334–6. PMID 9415695. doi:10.1002/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J.
De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis 24 (4): 367–79. PMID 9763354. doi:10.1055/s-2007-996025.
Bertina RM, Koeleman BP, Koster T, et al. (maio de 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature 369 (6475): 64–7. PMID 8164741. doi:10.1038/369064a0.
Rodger MA, Paidas M, McLintock C, et al. (agosto de 2008). "Inherited thrombophilia and pregnancy complications revisited". Obstetrics and Gynecology 112 (2 Pt 1): 320–24. PMID 18669729. doi:10.1097/AOG.0b013e31817e8acc.

genome.gov

What do we know about heredity and factor V Leiden thrombophilia? http://www.genome.gov/15015167#Q5

haematologica.org

De Stefano V, Leone G (1995). "Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia". Haematologica 80 (4): 344–56. PMID 7590506.

msssi.gob.es

eciemaps.msssi.gob.es

No CIE-9 (289.81) a doenza denomínase "mutación del factor V de Leiden". [1] Arquivado 03 de outubro de 2018 en Wayback Machine.

nih.gov

ncbi.nlm.nih.gov

De Stefano V, Leone G (1995). "Resistance to activated protein C due to mutated factor V as a novel cause of inherited thrombophilia". Haematologica 80 (4): 344–56. PMID 7590506.
Ridker PM, Miletich JP, Hennekens CH, Buring JE (1997). "Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening". JAMA 277 (16): 1305–7. PMID 9109469. doi:10.1001/jama.277.16.1305.
Gregg JP, Yamane AJ, Grody WW (decembro de 1997). "Prevalence of the factor V-Leiden mutation in four distinct American ethnic populations". American Journal of Medical Genetics 73 (3): 334–6. PMID 9415695. doi:10.1002/(SICI)1096-8628(19971219)73:3<334::AID-AJMG20>3.0.CO;2-J.
De Stefano V, Chiusolo P, Paciaroni K, Leone G (1998). "Epidemiology of factor V Leiden: clinical implications". Seminars in Thrombosis and Hemostasis 24 (4): 367–79. PMID 9763354. doi:10.1055/s-2007-996025.
Bertina RM, Koeleman BP, Koster T, et al. (maio de 1994). "Mutation in blood coagulation factor V associated with resistance to activated protein C". Nature 369 (6475): 64–7. PMID 8164741. doi:10.1038/369064a0.
Williamson D, Brown K, Luddington R, Baglin C, Baglin T. Factor V Cambridge: a new mutation (Arg306-->Thr) associated with resistance to activated protein C. Blood. 1998 Feb 15;91(4):1140-4. PMID 9454742.
"SNP linked to Gene F5". NCBI.
Mari Tinholt, Marte Kathrine Viken, Anders Erik Dahm, Hans Kristian Moen Vollan, Kristine Kleivi Sahlberg, Øystein Garred, Anne-Lise Børresen-Dale, Anne Flem Jacobsen, Vessela Kristensen, Ida Bukholm, Rolf Kåresen, Ellen Schlichting, Grethe Skretting, Benedicte Alexandra Lie, Per Morten Sandset, e Nina Iversen. Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study. BMC Cancer. 2014; 14: 845. Publicado en liña o19 de novembro de 2014. doi: 10.1186/1471-2407-14-845. PMCID: PMC4251949. PMID 25407022.
Rodger MA, Paidas M, McLintock C, et al. (agosto de 2008). "Inherited thrombophilia and pregnancy complications revisited". Obstetrics and Gynecology 112 (2 Pt 1): 320–24. PMID 18669729. doi:10.1097/AOG.0b013e31817e8acc.

pharmgkb.org

Bushwitz, Jennifer; Pacanowski, Michael A. & Johnson,Julie A. (2006-10-11). "Very Important Pharmacogene: F5". PharmGKB.

web.archive.org

No CIE-9 (289.81) a doenza denomínase "mutación del factor V de Leiden". [1] Arquivado 03 de outubro de 2018 en Wayback Machine.